Contrast-Enhanced Ultrasound Identification of Sentinel Nodes in Esophageal Cancer

Summary

This pilot trial studies how well an ultrasound with a contrast agent (perflubutane microbubble \[Sonazoid\]) works in identifying sentinel lymph nodes in participants with esophageal cancer. Sentinel lymph nodes are lymph nodes to which the cancer is likely to spread from the primary tumor. Diagnostic procedures, such as contrast-enhanced ultrasound, may work better in identifying sentinel lymph nodes and finding out how far the disease has spread.

Timeline

Start

2018-09-06

Primary completion

2022-08-25

Completion

2022-08-25

Drugs

Indications